tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Ownership - Who Owns Relay Therapeutics?

Compare
429 Followers

Relay Therapeutics (RLAY) Ownership Overview

2.95%19.29%49.01%15.54%13.22%
49.01% Other Institutional Investors
15.54% ETFs
13.22% Public Companies and Individual Investors
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 83.84% of the company’s stock is owned by Institutional Investors, 2.95% is owned by Insiders, and 13.22% is owned by Public Companies and Individual Investors.
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 68.29% of the company’s stock is owned by Institutional Investors, 2.95% is owned by Insiders, and 15.54% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 13, 2025
Sanjiv Patel
President & Ceo,director
xxxxxxxxxxxxx
$818400
Jan 30, 2025
xxxxxxxxxxxxx
$248173
Jan 30, 2025
xxxxxxxxxxxxx
$247872
Jan 30, 2025
Donald A Bergstrom
President, R&d
xxxxxxxxxxxxx
$362298

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$70800
Dec 31, 2024
xxxxxxxxxxxxx
$186685
Dec 31, 2024
xxxxxxxxxxxxx
$1960480

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
14,220,066Institution8.50%56,880,264
12,784,014Institution7.64%51,136,056
6,166,150Institution3.68%24,664,600
2,924,599Institution1.75%11,698,396
2,682,083Institution1.60%10,728,332
2,607,991Institution1.56%10,431,964
2,123,364Institution1.27%8,493,456
1,769,992Insider1.06%7,079,968
1,299,567Institution0.78%5,198,268
1,160,117Institution0.69%4,640,468

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
12,784,014Institution7.64%51,136,056
2,682,083Institution1.60%10,728,332
2,607,991Institution1.56%10,431,964
2,123,364Institution1.27%8,493,456
1,299,567Institution0.78%5,198,268
1,130,586Institution0.68%4,522,344
1,120,018Institution0.67%4,480,072
1,101,015Institution0.66%4,404,060
958,411Institution0.57%3,833,644
774,990Institution0.46%3,099,960

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,857,680Institution2.90%20,013,642
4,049,434Institution2.42%16,683,668
3,295,217Institution1.97%13,180,868
2,671,521Institution1.60%10,579,223
2,293,577Institution1.37%9,449,537
1,952,020Institution1.17%8,042,322
1,150,976Institution0.69%4,603,904
759,461Institution0.45%3,037,844
627,955Institution0.38%2,486,702
575,570Institution0.34%2,371,348

FAQ

Who Owns Relay Therapeutics (RLAY)?
According to the latest TipRanks data, approximately 49.01% of the company's stock is held by institutional investors, 2.95% is held by insiders, and 13.22% is held by retail investors.
    What percentage of Relay Therapeutics (RLAY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 49.01% of Relay Therapeutics (RLAY) stock is held by institutional investors.
      What percentage of Relay Therapeutics (RLAY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 13.22% of Relay Therapeutics (RLAY) stock is held by retail investors.
        Who owns the most shares of Relay Therapeutics (RLAY)?
        Vanguard owns the most shares of Relay Therapeutics (RLAY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis